We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002156:SZSETongfu Microelectronics Co.,Ltd Analysis

Data as of 2026-07-27 - not real-time

CN¥76.67

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Tongfu Microelectronics is trading well above its 20‑day (≈71.5) and 50‑day (≈68.4) moving averages, with the price sitting near the 52‑week high of 84.7 and a bullish MACD histogram confirming upward momentum. Volume has been on an upward trend, reinforcing the technical strength, while the RSI of 56 suggests the stock is not yet overbought. Fundamentally, the company posted a 22.8% revenue growth year‑over‑year and maintains a gross margin of roughly 14%, but operating efficiency is modest with an operating margin near 5.8%. The trailing PE of about 80× dwarfs the industry average of 33×, indicating that the market is pricing in a premium that may be hard to justify. A discounted cash‑flow model values the shares around 85 CNY, slightly above the current price of 76.7 CNY, yet analyst consensus targets cluster near 45‑50 CNY, implying a sizable downside. The balance sheet is heavily leveraged with a debt‑to‑equity ratio exceeding 115%, and free cash flow is negative, raising concerns about cash sustainability despite a modest dividend yield of 0.11% and a very low payout ratio.
Given the bullish technical setup but pronounced valuation stretch, high leverage, and volatile price swings (30‑day volatility ~95%), the stock is best approached with caution. The sector’s cyclical nature and China‑centric regulatory environment add medium‑high risk, while the low beta suggests limited market‑wide correlation. Investors seeking growth exposure may find short‑term upside, but the long‑term outlook is tempered by valuation and cash‑flow constraints. Accordingly, a balanced stance that leans toward buying on dips, while monitoring debt levels and analyst revisions, is advisable.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMA20/50, bullish MACD)
  • Increasing trading volume supporting momentum
  • Current price below DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and exposure to expanding semiconductor testing market
  • Potential upside to DCF valuation if cash flow improves
  • Analyst consensus still favorable (buy recommendation)

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High valuation multiples relative to peers
  • Elevated debt levels and negative free cash flow
  • Sector cyclicality and regulatory uncertainty in China

Key Metrics & Analysis

Financial Health

Revenue Growth22.80%
Profit Margin4.93%
P/E Ratio80.7
ROE9.67%
ROA2.65%
Debt/Equity116.57
P/B Ratio7.4
Op. Cash FlowCN¥6.4B
Free Cash FlowCN¥-2201262848
Industry P/E32.9

Technical Analysis

TrendBullish
RSI56.0
SupportCN¥57.00
ResistanceCN¥84.70
MA 20CN¥71.49
MA 50CN¥68.43
MA 200CN¥50.20
MACDBullish
VolumeIncreasing
Fear & Greed Index89.96

Valuation

Fair ValueCN¥85.40
Target PriceCN¥49.21
Upside/Downside-35.82%
GradeOvervalued
TypeGrowth
Dividend Yield0.11%

Risk Assessment

Beta0.05
Volatility95.44%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.